Cowen & Co Upgrades Biogen Idec (BIIB) to Outperform, Calls Best Value In Biotech
Tweet Send to a Friend
Cowen & Co upgrades Biogen Idec (Nasdaq: BIIB) to Outperform, calling the stock the Best Value in Biotech.
Cowen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


